Royal Bank of Canada »

Oncolytics Biotech shares owned by Royal Bank of Canada

Quarter-by-quarter ownership of Oncolytics Biotech (ONCY) shares owned by Royal Bank of Canada from 13F filings

Historical chart of Royal Bank of Canada investment in Oncolytics Biotech

Tip: Access up to 7 years of quarterly data

All positions including Oncolytics Biotech held by Royal Bank of Canada consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Oncolytics Biotech by Royal Bank of Canada

Quarter filed Position value Share count Share price at filing
2026-06-30 $55k 57k 0.96

More positions owned by Royal Bank of Canada

State Str Spdr S&p 500 Etf T Tr Unit (SPY)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Rbc Cad (RY)
Alphabet Cap Stk Cl A (GOOGL)
Microsoft Corporation (MSFT)
Toronto Dominion Bk Ont Com New (TD)
Amazon (AMZN)
Ishares Tr Core S&p500 Etf (IVV)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Bank Of Montreal Cadcom (BMO)
Alphabet Cap Stk Cl C (GOOG)
Cibc Cad (CM)
Broadcom (AVGO)
JPMorgan Chase & Co. (JPM)

View all positions for Royal Bank of Canada

Top funds holding Oncolytics Biotech

Marshall Wace
XTX Topco
Seeds Investor
International Assets Investment Management
Connective Capital Management
Goldman Sachs Group
Tocqueville Asset Management
Everhart Financial Group
Susquehanna International
PFG Investments
Hrt Financial
Invesco
Doliver Capital Advisors
LPL Financial
Franklin Resources

View all funds holding Oncolytics Biotech